FlowTriever for Acute Massive Pulmonary Embolism (FLAME) (FLAME)
Sponsor: Inari Medical
This observational or N/A phase trial investigates PE - Pulmonary Embolism and PE - Pulmonary Thromboembolism and is currently completed. Inari Medical leads this study, which shows 11 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
May 2025 — Present [monthly]
Completed
-
Oct 2024 — May 2025 [monthly]
Completed
-
Sep 2024 — Oct 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2023 — Jul 2024 [monthly]
Completed
▶ Show 6 earlier versions
-
Feb 2023 — Oct 2023 [monthly]
Completed
Status: Enrolling By Invitation → Completed
-
Sep 2022 — Feb 2023 [monthly]
Enrolling By Invitation
-
Nov 2021 — Sep 2022 [monthly]
Enrolling By Invitation
-
Sep 2021 — Nov 2021 [monthly]
Enrolling By Invitation
-
May 2021 — Sep 2021 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Apr 2021 — May 2021 [monthly]
Not Yet Recruiting
First recorded
Mar 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Inari Medical
For direct contact, visit the study record on ClinicalTrials.gov .